BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29479063)

  • 21. T-cell lymphoblastic leukemia/lymphoma with t(7;14)(p15;q32) [TCRγ-TCL1A translocation]: a case report and a review of the literature.
    Sugimoto KJ; Shimada A; Wakabayashi M; Sekiguchi Y; Izumi H; Ota Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(5):2615-23. PubMed ID: 24966976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JAK1 mutation analysis in T-cell acute lymphoblastic leukemia cell lines.
    Porcu M; Gielen O; Cools J; De Keersmaecker K
    Haematologica; 2009 Mar; 94(3):435-7. PubMed ID: 19176360
    [No Abstract]   [Full Text] [Related]  

  • 23. Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma.
    Marín-Rubio JL; de Arriba MC; Cobos-Fernández MA; González-Sánchez L; Ors I; Sastre I; Fernández-Piqueras J; Villa-Morales M
    Oncotarget; 2016 Sep; 7(38):61485-61499. PubMed ID: 27556297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations.
    La Starza R; Borga C; Barba G; Pierini V; Schwab C; Matteucci C; Lema Fernandez AG; Leszl A; Cazzaniga G; Chiaretti S; Basso G; Harrison CJ; Te Kronnie G; Mecucci C
    Blood; 2014 Dec; 124(24):3577-82. PubMed ID: 25270907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms.
    Motylewska E; Braun M; Stępień H
    Endocr Pathol; 2020 Sep; 31(3):264-273. PubMed ID: 32504181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Pim kinases in hematological cancers: molecular and clinical review.
    Bellon M; Nicot C
    Mol Cancer; 2023 Jan; 22(1):18. PubMed ID: 36694243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous rearrangements of TAL1 and LMO2 in T-cell acute lymphoblastic leukemia.
    Kim HK; Lim JH; Koh KN; Chi HS; Seo EJ
    Int J Lab Hematol; 2014 Oct; 36(5):e69-70. PubMed ID: 24330618
    [No Abstract]   [Full Text] [Related]  

  • 28. Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia.
    Porcu M; Kleppe M; Gianfelici V; Geerdens E; De Keersmaecker K; Tartaglia M; Foà R; Soulier J; Cauwelier B; Uyttebroeck A; Macintyre E; Vandenberghe P; Asnafi V; Cools J
    Blood; 2012 May; 119(19):4476-9. PubMed ID: 22438252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement.
    Chae H; Lim J; Kim M; Park J; Kim Y; Han K; Lee S; Min WS
    Ann Hematol; 2012 Feb; 91(2):193-201. PubMed ID: 21720744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
    Bardelli V; Arniani S; Pierini V; Pierini T; Di Giacomo D; Gorello P; Moretti M; Pellanera F; Elia L; Vitale A; Storlazzi CT; Tolomeo D; Mastrodicasa E; Caniglia M; Chiaretti S; Ruggeri L; Roti G; Schwab C; Harrison CJ; Almeida A; Pieters T; Van Vlierberghe P; Mecucci C; La Starza R
    Genes Chromosomes Cancer; 2021 Jul; 60(7):482-488. PubMed ID: 33611795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
    Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIM1 kinase as a target for cancer therapy.
    Merkel AL; Meggers E; Ocker M
    Expert Opin Investig Drugs; 2012 Apr; 21(4):425-36. PubMed ID: 22385334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human pim-1 gene is not directly activated by the translocation (6;9) in acute nonlymphocytic leukemia.
    von Lindern M; van Agthoven T; Hagemeijer A; Adriaansen H; Grosveld G
    Oncogene; 1989 Jan; 4(1):75-9. PubMed ID: 2644612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pim kinases in cancer: diagnostic, prognostic and treatment opportunities.
    Blanco-Aparicio C; Carnero A
    Biochem Pharmacol; 2013 Mar; 85(5):629-643. PubMed ID: 23041228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel translocation t(1;5)(p32;q31) that was not associated with the TAL1 rearrangement in a case of T lymphoblastic leukemia/lymphoma.
    Cho HS; Kim MK; Bae YK
    Korean J Lab Med; 2009 Jun; 29(3):199-203. PubMed ID: 19571616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia.
    Alcantara M; Simonin M; Lhermitte L; Touzart A; Dourthe ME; Latiri M; Grardel N; Cayuela JM; Chalandon Y; Graux C; Dombret H; Ifrah N; Petit A; Macintyre E; Baruchel A; Boissel N; Asnafi V
    Blood Adv; 2019 Jul; 3(13):1981-1988. PubMed ID: 31270080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PIM kinases 1, 2 and 3 in intracellular LIF signaling, proliferation and apoptosis in trophoblastic cells.
    Mary Photini S; Chaiwangyen W; Weber M; Al-Kawlani B; Favaro RR; Jeschke U; Schleussner E; Morales-Prieto DM; Markert UR
    Exp Cell Res; 2017 Oct; 359(1):275-283. PubMed ID: 28729093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia.
    Cheng H; Huang C; Xu X; Hu X; Gong S; Tang G; Song X; Zhang W; Wang J; Chen L; Yang J
    J Transl Med; 2017 Aug; 15(1):179. PubMed ID: 28851457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development.
    Roncero AM; López-Nieva P; Cobos-Fernández MA; Villa-Morales M; González-Sánchez L; López-Lorenzo JL; Llamas P; Ayuso C; Rodríguez-Pinilla SM; Arriba MC; Piris MA; Fernández-Navarro P; Fernández AF; Fraga MF; Santos J; Fernández-Piqueras J
    Leukemia; 2016 Jan; 30(1):94-103. PubMed ID: 26216197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.
    Danis E; Yamauchi T; Echanique K; Zhang X; Haladyna JN; Riedel SS; Zhu N; Xie H; Orkin SH; Armstrong SA; Bernt KM; Neff T
    Cell Rep; 2016 Mar; 14(8):1953-65. PubMed ID: 26904942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.